Previous Article | Next Article ![]()
Infection and Immunity, October 2005, p. 6912-6922, Vol. 73, No. 10
0019-9567/05/$08.00+0 doi:10.1128/IAI.73.10.6912-6922.2005
Copyright © 2005, American Society for Microbiology. All Rights Reserved.
Pascale Cossart,1* and
Hélène Bierne1*
Unité des Interactions Bactéries-Cellules, Institut Pasteur, INSERM U604, INRA USC2020, 75724 Paris Cedex 15, France,1 Service des Maladies infectieuses et tropicales, Université Paris 5, Hôpital Necker-Enfants maladies, 75015 Paris, France2
Received 14 March 2005/ Returned for modification 2 May 2005/ Accepted 11 June 2005
|
|
|---|
ORF2568 strain showed a slight increase in virulence. inlJ encodes a leucine-rich repeat (LRR) protein that is structurally related to the listerial invasion factor internalin. However, the consensus sequence of the InlJ LRR defines a novel subfamily of cysteine-containing LRRs in bacteria. In conclusion, this postgenomic approach identified InlJ as a new virulence factor among the proteins belonging to the internalin family in L. monocytogenes. |
|
|---|
Several listerial surface proteins play key roles in listerial interactions with mammalian host cells (8). One of these proteins, internalin (InlA), promotes Listeria internalization in epithelial cells by interacting with the host adhesion protein E-cadherin (51) and is required for invasion of intestinal and placental villi in vivo (38, 40). InlA possesses an N-terminal leucine-rich repeat (LRR) domain (59) and a C-terminal sorting signal, including an LPXTG motif. Anchoring of InlA to the bacterial surface is achieved by sortase A (SrtA) (6), a transpeptidase that cleaves the LPXTG motif between the threonine and glycine residues and covalently links the threonine to the peptidoglycan (12, 16, 48, 61). Inactivation of srtA in L. monocytogenes inhibits anchoring of LPXTG proteins to the cell wall and attenuates virulence following intravenous or oral infection in mice (6, 27). The Listeria genome encodes another sortase, SrtB, which seems to have only two substrates carrying an NXZTN motif instead of LPXTG and which is not required for the infectious process in mice (5).
A better understanding of listeriosis pathophysiology relies on identification of new bacterial virulence factors and their characterization in adapted animal models. Intravenous inoculation of mice has proven to be a good route to study the virulence factors involved in the intracellular life of L. monocytogenes (18, 35). However, bacterial translocation across the intestinal barrier is inefficient in the mouse (40). In contrast, in guinea pigs and in transgenic mice expressing human E-cadherin, the internalin receptor (40), in enterocytes (hEcad mice), bacteria can efficiently cross the intestinal epithelial barrier and gain access to deeper tissues. These two models thus appear to be more appropriate than a normal mouse model for studying listeriosis acquired via the oral route (37), which is the natural route for infection in humans (57).
In the past few years, major listerial virulence factors have been identified by using classical genetic approaches, such as generation of transposition mutants and characterization of these mutants in infection experiments in cultured cells (18, 35). Determination and comparison of the genome sequences of L. monocytogenes and the nonpathogenic closely related species Listeria innocua (28) have now paved the way for identifying new virulence factors (8, 14, 28, 53). Such a comparative approach has, for instance, led to the identification of a bile salt hydrolase (17) and an autolysin (9) as new factors involved in Listeria infections. Besides whole-genome comparisons, a Listeria DNA array has recently been generated to study inter- and intraspecies diversity (14). This macroarray, which harbors specific genes from three sequenced strains, two pathogenic L. monocytogenes strains (serovars 1/2a and 4b) and a nonpathogenic L. innocua strain, was used to analyze the DNA content and genomic biodiversity of 113 Listeria strains of different species and serovars. Hybridization results identified L. monocytogenes-specific marker genes, including inlA and other previously identified virulence factors, such as hly, actA, or inlB, as well as serovar-specific marker genes. It is now well established that L. monocytogenes strains do not appear to be equally able to generate disease in humans (30). Only 4 of the 13 serovars identified in this species, serovars 1/2a, 1/2c, 1/2b, and 4b, are responsible for the reported human listeriosis cases (31). Notably, serotype 4b strains are overrepresented compared with the strains of other serotypes among the organisms responsible for outbreaks and sporadic cases of listeriosis (63).
In this work, we first confirmed that srtA inactivation strongly attenuates Listeria virulence in orally acquired listeriosis, supporting the role of LPXTG surface proteins in the infectious process. Then, by exploiting the genome and biodiversity array data, we addressed the role of four previously uncharacterized LPXTG protein-encoding genes, two L. monocytogenes-specific genes and two genes present in a subset of serovars, including serovar 4b. We generated deletion mutants and analyzed them in vitro and in vivo. This work revealed the role of the lmo2821 gene product, InlJ, an LRR cysteine-containing protein, in orally acquired listeriosis. In addition, inactivation of the ORF2568 gene in L. monocytogenes serovar 4b slightly increased bacterial virulence, suggesting that the gene product has a role in virulence modulation.
|
|
|---|
|
View this table: [in a new window] |
TABLE 1. Bacterial strains and plasmids
|
inlI and
inlJ L. monocytogenes EGDe deletion mutants.
Two
650-bp fragments flanking the target gene (inlI or inlJ) were amplified by PCR from EGDe chromosomal DNA with primers inside and outside the inlI and inlJ loci. The primers used for the inlI 5' flanking fragment were i1 (5'-CGCGGATCCTGCGGTATCAAGAAGTTTATC-3') and i2 (5'-AAAAGGCCTCTTTTTCAAGACTTTCCCTCT-3'), and the primers used for the 3' fragment were i3 (5'-AAAAGGCCTACGAACCAATAAATGGATAAAC-3') and i4 (5'-TCCCCCGGGCGGAGTTGCTGTGTATCTAGT-3'). The primers used for the inlJ 5' flanking fragment were j1 (5'-CGCGGATCCTAGCAGAAGATGGAACCC-3') and j2 (5'-AAAAGGCCTAGTTTTCAATTTGGCGCACTC-3'), and the primers used for the 3' fragment were j3 (5'-AAAAGGCCTAAATAGTAAAAAAGCCGGACA-3') and j4 (5'-CCGGAATTCCAAATGATGTTATCGGTCAGC-3'). After restriction of the amplified 5' and 3' fragments with BamHI and StuI or StuI and SmaI (for
inlI construction) and with BamHI and StuI or StuI and EcoRI (for
inlJ construction), 5' and 3' fragments were coligated in the thermosensitive plasmid pMAD digested by BamHI and SmaI or by BamHI and EcoRI, yielding the pMAD-
inlI and pMAD-
inlJ plasmids. These plasmids were electroporated into L. monocytogenes strain EGDe, and gene replacement was performed as described previously (1) but at a nonpermissive temperature growth, 43.5°C, resulting in in-frame deletions of the inlI or inlJ genes.
(ii) Construction of the in-frame
ORF29 and
ORF2568 deletion mutants in L. monocytogenes serovar 4b strain.
ORF29 and
ORF2568 were constructed as described above for the
inlI and
inlJ strains, with the following modifications. The primers used for
ORF29 construction were k1 (5'-CGCGGATCCGTGAGCCTATGTACGGTC-3'), k2 (5'-AAAAGGCCTCACAGAAAAGCCCCCTTA-3'), k3 (5'-AAAAGGCCTAGAAGTTAAACCACTCCAT-3') for the 5' and 3' flanking fragments, respectively, and k4 (5'-CCGGAATTCCCATTAAAGAAGCAGAACA-3'), and the primers used for
ORF2568 construction were l1 (5'-CGCGGATCCCGTCATATATCAATCTCCAT-3'), l2 (5'-AAAAGGCCTCATTTTTTTTGCCCCTTCAA-3'), l3 (5'-AAAAGGCCTTAAAAAAACGCCCAGTATTTG-3'), and l4 (5'-TCCCCCGGGTCTCCAAGCCACAATCAC-3') for the 5' and 3' flanking fragments, respectively. The enzymes used for the construction of pMAD-
ORF29 and pMAD-
ORF2568 were BamHI, StuI, and EcoRI for pMAD-
ORF29 and BamHI, StuI, and SmaI for pMAD-
ORF2568.
Mutant verification by PCR and sequencing.
Mutants were verified by PCR analysis of chromosomal DNA using pairs of oligonucleotide primers inside genes, including i7 (5'-CGGAGCGCCTGTCATTTC-3') and i8 (5'-TACGCCGTCTTCATTCGT-3') for
inlI, j7 (5'-GAGGCTGAAGGGCAAACAATC-3') and j8 (5'-CATCCGCCAATTTTTCTCCTT-3') for
inlJ, k7 (5'-GGGAGGAACTCTTTTAGTGTC-3') and k8 (5'-GCTTGGTACAATGAGTGTACT-3') for
ORF29, and l7 (5'-CATCTTCAAGATCAAGCATTA-3') and l8 (5'-GCTAACTTATTTCCATCACCA-3') for
ORF2568, and pairs of oligonucleotide primers in regions flanking the genes, including i5 (5'-GCGTACTCATTTAAGACGAAT-3') and i6 (5'-AAGCCTCTCTTTAATGGACAG-3') for
inlI, j5 (5'-ATAAATACGCCTCGCTTA-3') and j6 (5'-GACTAGTTTTGATGTGGA-3') for
inlJ, k5 (5'-TCTAGCGGGAATACTTGGGTT-3') and k6 (5'-GCAGGAGCAACATTCGGTTGG-3') for
ORF29, and l5 (5'-AGGCGAGCTAGAACATAATAC-3') and l6 (5'-CTGCTTCCAAAAGCAACAATC-3') for
ORF2568. Amplified fragments from
inlI,
inlJ,
ORF29, and
ORF2568 strain chromosomal DNA, obtained by using primers i5 and i6, primers j5 and j6, primers k5 and k6, and primers l5 and l6, respectively, were verified by sequencing.
RNA techniques. RNA from Listeria was isolated and purified with an RNAeasy kit (QIAGEN). Briefly, cultures of Listeria were centrifuged at 4,000 x g for 6 min. The pellets were resuspended in 100 µl of Tris-EDTA and 250 µl of RNAeasy lysis buffer and transferred to a Bead Beater tube containing 0.4 g of mini glass beads (Sigma). Bacteria were broken mechanically using a Fast Prep apparatus (Bio 101) and centrifuged (13,000 x g, 1 min), and the supernatants were transferred and treated according to the manufacturer's procedure. DNA contaminants were eliminated with a DNase kit (Ambion). The presence of the inlI, inlJ, ORF29, and ORF2568 genes in wild-type and mutants strains was assed by amplification of internal fragments by reverse transcriptase (RT)-PCR, using Superscript one-step RT-PCR (Invitrogen) and the internal primers described above. The absence of DNA contamination of the RNA was checked by PCR. For mutant verification, bacteria were grown to an optical density at 600 nm (OD600) of 0.6. Primers iap-F (5'-AAAGCAACTATCGCGGCTAC-3') and iap-R (5'-TCTTGAACAGAAACACCGTA-3'), which amplify the iap gene encoding the p60 protein, were used as a control for RNA amplification. In the semiquantitative PCR assay, bacteria were grown to an OD600 of 0.8, as in the gentamicin survival assay (see below). Primers inlA-1 (5'-CATCACCTTATATGCCCAATATAGC-3') and inlA-2 (5'-GATTTTTCGTAAATTGAGCGTACAG-3') and primers gyrA-1 (5'-AACTTTGGTTCGGTTGATGG-3') and gyrA-2 (5'-TGGCTCACGTTCAGAACC-3'), which amplify the inlA and gyrA genes, respectively, were used as controls for known expressed genes.
Gentamicin survival assay. A gentamicin survival assay was performed as described previously (25, 51). Briefly, the Listeria strains were grown in BHI medium to an OD600 of 0.8 to 1, washed in phosphate-buffered saline, and diluted in DMEM, so that the multiplicity of infection was about 50 bacteria per cell. Bacterial suspensions were added to mammalian cells for 1 h, the cells were washed, and the noninvasive bacteria were killed by adding 10 µg/ml gentamicin for 2 h. After washing, the cells were lysed in 0.2% Triton X-100, and the number of viable bacteria released from the cells was assessed by plating on agar plates.
In vivo experiments. Four animals were used for each experiment, and all experiments were reproduced at least once and gave similar results. Prior to oral infection, the animals were starved to prevent variations linked to gastric repletion, which may influence intragastric bacterial survival. Statistical analyses were performed using the Student t test. P values of <0.05 were considered statistically significant. All animals were treated in accordance with Institut Pasteur guidelines for laboratory animal husbandry.
(i) Guinea pig oral infections. Experiments were performed as described previously (40). Briefly, 300-g male Hartley guinea pigs (Charles River) were starved for 2 days and anesthetized (15 mg/ml ketamine injected intramuscularly). Five milliliters of a 25-mg/ml CaCO3 solution in phosphate-buffered saline was injected intragastrically, followed by 1 ml of a sublethal bacterial inoculum (2.5 x 1010 CFU). After 96 h of infection, spleens, livers, and the whole mesenteric lymph nodes were sterilely dissected. The central 20-cm portion of the guinea pig small intestine was rinsed in DMEM (Gibco) to remove the intestinal contents, incubated at 20°C for 2 h in DMEM containing 100 mg/liter gentamicin (Gibco) to kill the extracellular bacteria from the intestinal lumen, and rinsed three times in DMEM. For bacterial enumeration, the numbers of CFU were determined by plating serial dilutions of organ (intestine, mesenteric lymph node, liver, and spleen) homogenates on BHI agar.
iFABP-hEcad transgenic mouse oral infections. iFABP-hEcad transgenic mice (40) were starved for 1 day and anesthetized. Three hundred microliters of a 50-mg/ml CaCO3 solution was injected intragastrically along with 200 µl of a sublethal bacterial inoculum (109 CFU). After 72 h of infection, spleens, livers, and the whole mesenteric lymph nodes were sterilely dissected. The central long portion of the mouse small intestine was rinsed in DMEM (Gibco) to remove the intestinal contents, incubated at 20°C for 2 h in DMEM containing 100 mg/liter gentamicin (Gibco) to kill the extracellular bacteria from the intestinal lumen, and rinsed three times in DMEM. For bacterial enumeration, the numbers of CFU were determined by plating serial dilutions of organ (intestine, mesenteric lymph node, liver, and spleen) homogenates on BHI agar.
Mouse intravenous infections. Bacterial growth in mice was studied by injecting 4- to 6-week-old specific-pathogen-free female BALB/c mice (Charles River) intravenously with a sublethal bacterial inoculum (104 CFU). At 24, 48, and 72 h after infection, the livers and spleens were sterilely dissected, and the numbers of CFU were determined by plating serial dilutions of organ (liver and spleen) homogenates on BHI agar.
|
|
|---|
inlA strain. We also addressed the effect of inactivating the second sortase gene, srtB. Quantification of the level of infection in the small intestine, mesenteric lymph nodes, liver, and spleen was used as a measure of virulence. Guinea pigs were orally infected with the L. monocytogenes wild-type reference strain EGDe or with srtA, inlA, or srtB isogenic deletion mutants. Bacterial counts in the organs were determined 96 h postinfection, which corresponded to the peak for the bacterial load in this animal model (40). For the
srtA strain there were decreases in the bacterial counts of 3 log10 in the intestine and liver and 2 log10 in the mesenteric lymph nodes compared to the wild-type strain and decreases of 1 log10 in both organs compared to the
inlA strain (Fig. 1). No
srtA or
inlA bacteria were recovered from spleens. In contrast to the
srtA strain, the
srtB strain did not exhibit a virulence defect. These results confirmed that at least one SrtA substrate other than InlA plays a role in the intestinal and hepatic phases of orally acquired listeriosis, which is consistant with our previous results for mice (6). Moreover, they strongly suggest that some LPXTG proteins play an additive role along with InlA in the crossing of the intestinal barrier.
![]() View larger version (14K): [in a new window] |
FIG. 1. srtA is involved in L. monocytogenes oral infections in guinea pigs. The wild-type EGDe strain (wt) and isogenic srtA, inlA, and srtB strains were orally inoculated into guinea pigs, as described in Materials and Methods. Animals were euthanized 96 h after infection, and organs were recovered, homonogenized, and plated. The numbers of bacteria able to colonize the intestine, mesenteric lymph nodes (M.L.N), liver, and spleen are expressed in log10 CFU. In each experiment four animal were used for each bacterial strain. The results are representative of two independent experiments. An asterisk indicates a significant difference (P < 0.05) between a mutant strain and the wild-type strain.
|
inlA,
inlB,
inlH, and
inlGHE strains have been shown to be attenuated in virulence (18, 35, 38, 40, 55, 58), while the contributions of the lmo0333 and lmo2821 genes have never been studied. Therefore, we focused on the lmo0333 and lmo2821 genes in this study.
Predicted structures of the internalin-like proteins Lmo0333 (InlI) and Lmo2821 (InlJ).
lmo0333 (5,337 bp) and lmo2821 (2,556 bp) are predicted to encode structurally related proteins consisting of 1,778 and 851 amino acids, respectively. The two proteins possess an N-terminal signal sequence followed by an LRR domain consisting of 28 and 15 LRRs, respectively, a domain characteristic of internalin family members (8, 15). Given this structural characteristic, Lmo0333 and Lmo2821 were desiganted InlI and InlJ. InlI is the largest internalin among the 19 internalin-like proteins present in the EGDe strain (8). As in InlA and in other described internalins (58), the LRR domains of both InlI and InlJ are followed by a conserved immunoglobulin-like domain, a variable region, and a C-terminal sorting signal that includes an LPXTG motif. The variable regions of InlI and InlJ contain specific repeats that are
70 residues long reported to be MucBP (mucin binding protein) domains (previously DUF1085; accession number PF06458) (Fig. 2A). MucBP domains are found in conjunction with an LRR domain and an LPXTG sorting signal in several bacterial peptidoglycan-bound proteins, especially in Listeria and Lactobacillis species. The InlI and InlJ proteins contain three and four MucBP domains, respectively. The InlI variable region also contains a PKD (polycystin kidney disease) repeat region (8) related to that found in the human membrane polycystin kidney disease protein (4).
![]() View larger version (34K): [in a new window] |
FIG. 2. InlJ LRR defines a new family of bacterial cysteine-containing LRRs. (A) Amino acid sequence of the inlJ gene product. The signal peptide is indicated by boldface letters. The 15 LRRs are aligned, with leucines, isoleucines, and valines indicated by a red background and cysteines indicated by a blue background. The other conserved residues are indicated by colored letters. The immunoglobulin (Ig)-like domain is indicated by a gray background. The four MucBP repeats are aligned with conserved residues in boldface letters. The LPXTG motif in the C-terminal sorting signal is underlined, and the hydrophobic residues are indicated by italics. (B) Comparison of InlA and InlJ LRR consensus sequences. Residue positions are numbered as described by Schubert et al. (58). The positions of the expected ß strand and 310-helix are indicated. Conserved residues are indicated by colored letters (hydrophobic core, red; cysteines, blue). (C) Alignment of LRR consensus sequences of InlJ and proteins from different species. (Top) Alignment of InlJ LRR with LRRs of bacterial or viral proteins. (Bottom) Alignment of InlA and InlJ LRR consensus sequences with LRRs of RNase inhibitor (RI) and cysteine-containing (CC) types from eukaryotes. Conserved residues are indicated by colored letters (leucines, valines, and isoleucines, red; cysteines, dark blue; threonine, light blue; asparagine, green; aspartic acid, orange). O, hydrophobic residues; bCC, bacterial cysteine containing.
|
Only one other internalin-like protein in L. monocytogenes, Lmo0331, and its ortholog in L. innocua, Lin0354, contain LRRs of the InlJ type. We also found LRRs in proteins from five other bacterial species (Fig. 2C). Two proteins from entomopoxviruses may be related to this subfamily. Finally, several eukaryotic LRRs contain cysteines, but they are not at the same position as in the InlJ LRR consensus. This is the case for the RNase inhibitor LRR type and several proteins of the CC (cysteine-containing) subfamily (Fig. 2C) (33, 36). Thus, InlJ defines a new type of LRR in the internalin family in bacteria.
Effect of inlI or inlJ gene inactivation in the L. monocytogenes cellular infectious process in vitro. In the genome of L. monocytogenes EGDe, inlI is the first gene of a putative operon comprising seven other genes (28). Six of these genes are predicted to encode proteins with unknown functions, while one, lmo0339, exhibits similarities with a pyrophosphatase-encoding gene. Four genes in this operon, including inlI, are absent in the genome of L. innocua CLIP11262, a sequenced strain. The inlJ gene is also absent from the L. innocua genome, but the surrounding regions are identical in L. innocua and L. monocytogenes. inlJ is in the orientation opposite that of lmo2820, a gene encoding a protein with an N-terminal domain exhibiting similarities with the transcriptional AraC/XylS family of regulators (26). No specific recognition sequence for the Listeria virulence regulator PrfA precedes the inlI and inlJ genes. The expression of inlI and inlJ in bacteria grown in BHI medium in the late exponential phase at 37°C was assessed by RT-PCR and compared to that of inlA and gyrA genes, which encode the invasion protein InlA and gyrase, respectively. Expression products were detected in all cases, indicating that inlI and inlJ are transcribed in these conditions (Fig. 3A).
![]() View larger version (61K): [in a new window] |
FIG. 3. Expression of inlI and inlJ. (A) RT-PCR for total RNAs from the end of the exponential phase (OD600, 0.8) for cultures in BHI medium at 37°C of L. monocytogenes wild-type strain. Serial dilutions of the RNA templates were used. The gyrA and inlA genes were used as controls of known expressed genes. (B) RT-PCR for RNAs from L. monocyogenes wild-type and inlI or inlJ strains. Amplification of the iap gene was used to control RNA amounts. wt, wild type.
|
inlI and
inlJ strains displayed no growth defect in BHI medium at 37°C compared to the wild-type strain (data not shown). We then examined the ability of these strains to adhere to two epithelial cell lines, intestinal Caco-2 and placental JEG-3 cells, and to J774 macrophages, using previously described techniques (7, 15). After 1 h of infection at an initial multiplicity of infection of 50 bacteria per cell, the
inlI and
inlJ strains displayed no noticeable difference from the wild-type strain in adherence to host cells (data not shown). Then their ability to enter cells was examined by using nine different cell types, including epithelial and endothelial cells, hepatocytes, and macrophages. As shown in Table 2, the entry of the
inlI or
inlJ strain after 1 h of infection was similar to that of the wild-type strain for all cell types, suggesting that these genes are not involved in the L. monocytogenes internalization process. Finally, these mutants did not appear to be altered in intracellular multiplication, actin-based motility, and cell-to-cell spreading (data not shown). Taken together, these results indicate that the
inlI and
inlJ strains displayed no detectable defect in infection of tissue-cultured cells. |
View this table: [in a new window] |
TABLE 2. Determination of internalization efficiencies
|
inlI or
inlJ strain. Bacterial counts in the liver and spleen were determined 24, 48, and 72 h postinfection. As shown in Fig. 4A, at 72 h postinfection a 1-log10 decrease in the liver and spleen was observed for the inlJ mutant strain. In contrast, no difference was observed between
inlI and the wild-type strain. These results strongly suggest that InlJ contributes to Listeria virulence.
![]() View larger version (21K): [in a new window] |
FIG. 4. inlJ is involved in L. monocytogenes virulence. (A) Mice were inoculated intravenously with 104 CFU of the wild-type EGDe strain or inlI or inlJ strain. Bacterial growth was monitored in the liver and the spleen at 24 h, 48 h, and 72 h. The results are the means of two independent experiments. (B) hEcad mice were orally infected with 109 CFU of the wild-type strain or the inlI, inlJ, inlA, or srtA strain. The numbers of bacteria able to colonize the intestine, mesenteric lymph nodes (M.L.N), liver, and spleen were determined at 72 h. The data are expressed in log10 CFU (see Materials and Methods). In each experiment four animals were used for each bacterial strain. The results are the means of two ( inlI strain) or three (wild-type, inlJ, inlA, and srtA strains) independent experiments. An asterisk indicates a significant difference (P < 0.05) between a mutant strain and the wild-type strain. wt, wild type.
|
inlI and
inlJ strains were compared to those of wild-type,
inlA, and
srtA strains. After 72 h of infection, the
inlJ strain displayed 1- and 1.5-log10 decreases in colonization of the mesenteric lymph nodes and spleen, respectively, compared to the wild-type strain (Fig. 4B). This attenuation was comparable to that of
inlA and
srtA strains. The bacterial counts of the
inlJ strain were reduced 2 log10 in the liver, as observed for
inlA, while the
srtA strain displayed a more severe attenuation defect. Finally,
inlJ bacteria were recovered from intestines at a level of 3 x 103 CFU, a level intermediate between that of the wild-type strain (3 x 104 CFU) and that of
inlA and
srtA strains (3 x 102 CFU), which is at the limit of bacterial detection in this tissue. No significant attenuation in virulence was detected with the
inlI strain. Taken together, these results indicate that the inlJ gene product is involved in several steps of L. monocytogenes infection and validate the hypothesis that LPXTG-anchored proteins other than InlA are implicated in virulence when the oral route is used.
Inactivation of two other LPXTG protein-encoding gene markers for L. monocytogenes serovar 4b. L. monocytogenes serovar 4b strains are responsible for the majority of listeriosis epidemic cases, suggesting that this serovar expresses specific factors favoring infection in human. However, data generated with the biodiversity array did not reveal any gene that was present only in serovar 4b strains (14). Nevertheless, three genes encoding LPXTG proteins, ORF29, ORF1761, and ORF2568, were specifically detected in lineage II (serovars 1/2b, 4a, 4b, and 4c) and not in the other serovars (14). We therefore investigated whether these genes could be involved in L. monocytogenes serovar 4b infection. Reexamination of the sequence of ORF1761 revealed that this gene fused with ORF2017 and is present in serovar 1/2a. Therefore, we focused on the ORF29 and ORF2568 genes in this study.
Both ORF29 and ORF2568 are present in the three L. monocytogenes serovar 4b strains that have been sequenced (14, 53). ORF29 (1,470 bp) and ORF2568 (1,617 bp) are predicted to encode LPXTG proteins consisting of 489 and 538 amino acids, respectively, that do not possess an LRR domain but contain MucBP domains (Fig. 5A). Notably, the amino-terminal region encoded by ORF29 contains five hydrophobic repeats consisting of 22 amino acids of unknown structure and two repeated MucBP domains. The protein encoded by ORF2568 exhibits no similarity with known proteins except that it contains two MucBP domains separated by 156 amino acids.
![]() View larger version (23K): [in a new window] |
FIG. 5. (A) Schematic representation of ORF29 and ORF2568 LPXTG proteins specific for serovar 4b. The signal peptide (SP), repeat region, MucBP domains, and C-terminal sorting signal (solid box) are indicated. (B) Effect of ORF29 and ORF2568 inactivation on L. monocytogenes serovar 4b virulence. The wild-type L. monocytogenes serovar 4b strain or ORF29 and ORF2568 isogenic mutants were orally inoculated into hEcad mice (109 CFU). The numbers of bacteria able to colonize the intestine, mesenteric lymph nodes (M.L.N), liver, and spleen were determined at 72 h and expressed in log10 CFU (see Materials and Methods). In each experiment four animals were used for each bacterial strain. The results are the means of two ( ORF29 strain) or three (wild-type and ORF2568 strains) independent experiments. An asterisk indicates a significant difference (P < 0.05) between a mutant strain and the wild-type strain. wt, wild type. (C) Genetic organization of the ORF2568 region in L. monocytogenes serovar 4b strain CLIP80459 and in L. monocytogenes serovar 1/2a strain EGDe. Open reading frames are indicated according to the genome nomenclature described previously (ORF [14] and lmo [28]). Open reading frames present only in L. monocytogenes serovar 4b are indicated by solid arrows. Other open reading frames are indicated by open arrows. The ovals indicate putative transcription terminators.
|
ORF29 and
ORF2568 strains behaved like the wild-type strain (data not shown). These mutants were then tested in vivo by oral infection of transgenic hEcad mice, as described above for
inlI and
inlJ strains. As shown in Fig. 5A, the colonization of the intestine, mesenteric lymph nodes, liver, and spleen by the
ORF29 strain was similar to the colonization by the wild-type serovar 4b strain. In contrast, strikingly, for the
ORF2568 strain there was a reproducible and statistically significant slight increase in the number of CFU in the intestine, mesenteric lymph nodes, and spleen (Fig. 5B). Thus, the
ORF2568 bacteria displayed levels of colonization higher than those of the wild-type serovar 4b strain (0.5 log10 in the intestine, mesenteric lymph nodes, and liver and 1 log10 in the spleen). Together, these results indicate that ORF29 is not required for efficient L. monocytogenes serovar 4b oral infection, at least in the experimental conditions tested here. Moreover, inactivation of ORF2568 increased bacteriemia in tissues, suggesting that expression of this gene may affect L. monocytogenes virulence during host infection. The ORF2568 gene and the adjacent ORF3840 and ORF2763 genes are absent from the L. monocytogenes EGDe genome (Fig. 5C). These genes, whose functions are not known, are located in a chromosomal region which has not previously been associated with virulence or regulation. |
|
|---|
srtA strain is significantly more attenuated in virulence than a
inlA strain after oral infection in guinea pigs or hEcad mice, confirming the critical role of SrtA in bacterial invasion and/or persistence in deeper organs following oral infection (6). Therefore, it is likely that SrtA substrates other than InlA participate in different steps of the infectious process, from the crossing of the intestinal barrier to the hepatic phase of infection. The second sortase of L. monocytogenes, SrtB, which does not play any detectable role in virulence in the mouse (5), is not required for L. monocytogenes oral infection in guinea pigs. This suggests that the two SrtB substrates (5, 54) do not play major roles in food-borne listeriosis. In Staphylococcus aureus srtB inactivation moderately attenuates virulence, and detection of this effect requires long-term infection (32, 49).
Identification of a new virulence factor among internalin-LPXTG proteins. Consistant with the srtA attenuation phenotype, we identified a new virulence factor among the 41 LPXTG proteins encoded by L. monocytogenes EGDe (8, 28), the InlJ protein. Recent work in our laboratory has identified another LPXTG protein involved in orally acquired listeriosis, VIP, encoded by the lmo0320 gene (10). InlJ, in contrast to VIP, belongs to the internalin multigene family, which encompasses 25 genes in EGDe (8, 28). Internalins are characterized by the presence of an N-terminal LRR domain. Nineteen of these proteins, including InlA, have the LPXTG motif that is expected to anchor the protein to the peptidoglycan. One, InlB, is loosely attached to lipoteichoic acids at the bacterial surface. The last five, including InlC (13, 19), do not display any surface-targeting domain and are therefore expected to be secreted into the extracellular medium. InlA, InlH, InlB, and InlC are established virulence factors (18, 35, 58). Thus, InlJ extends the list of internalins involved in virulence.
inlJ is present only in L. monocytogenes among the Listeria species, as shown by PCR analysis of a small pool of virulent and avirulent strains (43) and confirmed on a larger scale by the use of DNA arrays (14). The inlJ mutant displays a virulence defect in both wild-type mice after intravenous infection and hEcad mice after oral infection, suggesting that it may be required at successive steps of listeriosis. Interestingly,
inlJ exhibits a 10-fold defect in intestinal colonization of hEcad mice, whereas
inlA has at least a 100-fold defect, which is at the limit of detection of L. monocytogenes in this tissue. In contrast, both mutants are similarly attenuated in the liver. InlA is probably the limiting factor among LPXTG proteins for efficient crossing of the intestinal epithelium by bacteria in hEcad mice, as it promotes Listeria internalization into enterocytes (40).
No phenotype could be attributed to the
inlJ strain in the cell culture system in vitro, making the function of inlJ elusive. As observed for inlJ, deletions of some other internalin genes, such as inlC or inlGHE, decrease the virulence in a mouse model but do not affect entry into epithelial cells, intracellular multiplication, or cell-to-cell spread (13, 15, 55). The various internalins may cooperate for efficient cell invasion, as proposed previously (3), or may have a totally different role in pathogenicity, such as interaction with the immune system.
Transcription of the inlJ gene is detectable by RT-PCR, similar to the inlA gene in bacteria grown in BHI medium at 37°C at the growth phase used for infection. However, we do not know yet at what level the encoded protein is produced. Using a highly sensitive gel-less method, Calvo et al. recently identified a pool of polypeptides linked to the L. monocytogenes EGDe peptidoglycan from bacteria grown in the same conditions (11). It is interesting that the InlJ protein was not detected in that pool, suggesting that its abundance at the bacterial surface is low. Of the 19 internalin-LPXTG proteins, only 5 were detected in cell wall extracts by this method (InlA, InlG, InlH, Lmo0327, and Lmo0610). This raises the possibility that InlJ synthesis, exportation, or anchoring at the bacterial surface might be low when bacteria are grown in BHI medium at 37°C and used to infect cultured cells. Interestingly, inlJ is adjacent to a gene encoding a putative transcriptional regulator, Lmo2820. Work is in progress to investigate where and when the InlJ protein is expressed and to address its possible regulation by the Lmo2820 protein.
InlJ defines a new subclass family of cysteine-containing LRR proteins. Sequence comparisons for the large group of LRR proteins suggest that there are several different subfamilies of LRR, which are characterized by different lengths and consensus sequences (33, 36). An LRR in internalins typically contains 22 residues. The LRR domain forms a curved solenoid with conserved leucines and isoleucines forming the hydrophobic core, as described for InlB, InlH, and InlA (44, 47, 58, 59). The InlJ consensus type described here is unusual in that it comprises 21 residues, possibly shortening the 310-helix, and displays a conserved cysteine at position 7 in place of a leucine (Fig. 2C). Cysteines are presumably part of the hydrophobic core of the molecule and may be protected from oxidation and therefore unlikely to form disulfide bonds. Only one cysteine in repeat 12 is not in the conserved position and could be accessible to an external ligand. Other internalin-like proteins containing LRRs of the InlJ type are found in Listeria species and in proteins from only five other bacterial species (Fig. 2C). Interestingly, all of them interact with mammalian hosts and are either commensals or pathogens.
A wide range of functions have been ascribed to LRR proteins, and these functions are related to the ability to bind structurally unrelated protein ligands (34, 36). This is exemplified by the specific interaction of the LRRs of InlA and InlB with at least two different cellular receptors, E-cadherin (39, 51, 59) and the hepatocyte growth factor receptor (60), respectively. In prokaryotes, several LRR proteins of pathogenic bacteria, such as secreted internalins in Listeria ivanovii (20), YopM in Yersinia (41, 50), IpaH in Shigella (22, 62), SspH in Salmonella (52), and Slr in Streptococcus (56), are known to play roles in host-pathogen interactions. LRRs in microorganisms may have been selected during evolution as a consequence of their structural similarities with mammalian LRR proteins, especially those involved in recognition of bacterial pathogens, such as TLR and NOD proteins (2, 29). It will be very interesting to identify the eukaryotic binding partner of InlJ.
Another putative structural feature of InlJ is the presence of MucBP domains, which are repeated four times in the C-terminal part of the protein (Fig. 2A). Identical motifs are present in InlI, ORF29, and ORF2568 and in several proteins bound to peptidoglycan of gram-positive bacteria (accession number PF06458). The function of these domains has not been elucidated.
Inactivation of the ORF2568 gene in L. monocytogenes serovar 4b increases virulence. Inactivation of two genes, ORF29 and ORF2568, encoding LPXTG proteins present in a subset of L. monocytogenes serovars, including epidemic serovar 4b, does not alter the listerial infectious process in vitro and does not attenuate Listeria virulence following oral infection. However, the bacterial loads of the ORF2568 deletion mutant in hEcad mice organs following oral inoculation, especially spleens, were increased compared to the loads of the wild-type serovar 4b strain. Inactivation of this gene may somehow affect the expression or function of other virulence factors and enhance the bacterial fitness in organs. Future work will address these possibilities.
In conclusion, this study showed the power of the postgenomic approach for successful identification of new virulence determinants. However, this candidate-based approach has its limitations. In contrast to InlA and InlB, whose role in Listeria-induced phagocytosis was identified following screening for noninvasive mutants in tissue-cultured cells (23), the InlJ function has not been determined. The challenge for the future is to identify the eukaryotic binding ligand and the signaling pathways triggered by the interaction with InlJ. In addition, in this study we could not identify any role for inlI or the serovar 4b LPXTG ORF29 gene in vitro or in virulence assays. These genes may not be required for pathogenesis but may function in another host or in specific infection conditions. Finally, the presence of multiple surface LPXTG proteins suggests that some of them may be important for virulence, while others may play a role in survival in food or other environments, which is critical for contamination.
Work in P. Cossart's laboratory received financial support from the Pasteur Institute (GPH N°9), INRA, INSERM, Ministère de l"Agriculture et de la Pêche (DGAL no. A 03/02), and the Ministère de l'Education Nationale, de la Recherche et de la Technologie (ACI Microbiology Mic0312). P.C. is an international research scholar of Howard Hughes Medical Institute. H.B. is on the INRA staff.
* Corresponding author. Mailing address: Unité des Interactions Bactéries-Cellules, Institut Pasteur, INSERM U604, INRA USC2020, 75724 Paris Cedex 15, France. Phone: 33 1 40 61 37 79. Fax: 011 33 1 45 68 87 06. E-mail: hbierne{at}pasteur.fr. ![]()
Present address: Institute for Molecular and Cell Biology, Molecular Microbiology Group, Rua do Campo Alegre, 823 4150-180 Porto, Portugal. ![]()
|
|
|---|
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»